Plasma steroid concentrations reflect acute disease severity and normalise during recovery in people hospitalised with COVID-19.
Saved in:
| Title: | Plasma steroid concentrations reflect acute disease severity and normalise during recovery in people hospitalised with COVID-19. |
|---|---|
| Authors: | Devine K; BHF/University Centre for Cardiovascular Science, Queen's Medical Research Institute, Edinburgh Bioquarter, University of Edinburgh, Edinburgh, UK.; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK., Russell CD; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, UK., Blanco GR; Edinburgh Cancer Research UK Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK., Walker BR; BHF/University Centre for Cardiovascular Science, Queen's Medical Research Institute, Edinburgh Bioquarter, University of Edinburgh, Edinburgh, UK.; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK., Homer NZM; BHF/University Centre for Cardiovascular Science, Queen's Medical Research Institute, Edinburgh Bioquarter, University of Edinburgh, Edinburgh, UK.; Mass Spectrometry Core, Edinburgh Clinical Research Facility, Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK., Denham SG; Mass Spectrometry Core, Edinburgh Clinical Research Facility, Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK., Simpson JP; Mass Spectrometry Core, Edinburgh Clinical Research Facility, Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK., Leavy OC; Department of Population Health Sciences, University of Leicester, Leicester, UK., Elneima O; NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK., McAuley HJC; NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK., Shikotra A; NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK., Singapuri A; NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK., Sereno M; NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK., Saunders RM; NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK., Harris VC; NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK., Houchen-Wolloff L; NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK., Greening NJ; NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK., Lone NI; Centre for Medical Informatics, The Usher Institute, University of Edinburgh, Edinburgh, UK., Thorpe M; Centre for Medical Informatics, The Usher Institute, University of Edinburgh, Edinburgh, UK., Greenhalf W; University of Liverpool, Liverpool, UK., Chalmers JD; Ninewells Hospital and Medical School, University of Dundee, Dundee, UK., Ho LP; MRC Human Immunology Unit, University of Oxford, Oxford, UK., Horsley A; Division of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Marks M; Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK.; Hospital for Tropical Diseases, University College London Hospital, London, UK.; Division of Infection and Immunity, University College London, London, UK., Raman B; Radcliffe Department of Medicine, University of Oxford, Oxford, UK., Moore SC; NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK., Dunning J; Pandemic Sciences Institute, University of Oxford, Oxford, UK., Semple MG; NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK., Andrew R; BHF/University Centre for Cardiovascular Science, Queen's Medical Research Institute, Edinburgh Bioquarter, University of Edinburgh, Edinburgh, UK.; Mass Spectrometry Core, Edinburgh Clinical Research Facility, Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK., Wain LV; Department of Population Health Sciences, University of Leicester, Leicester, UK.; NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK., Evans RA; NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK., Brightling CE; NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK., Kenneth Baillie J; Division of Genetics and Genomics, Roslin Institute, University of Edinburgh, Edinburgh, UK., Reynolds RM; BHF/University Centre for Cardiovascular Science, Queen's Medical Research Institute, Edinburgh Bioquarter, University of Edinburgh, Edinburgh, UK. |
| Corporate Authors: | ISARIC4C Investigators and PHOSP-COVID Study Collaborative Group |
| Source: | Clinical endocrinology [Clin Endocrinol (Oxf)] 2024 Apr; Vol. 100 (4), pp. 317-327. Date of Electronic Publication: 2024 Jan 17. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Blackwell Publishing Country of Publication: England NLM ID: 0346653 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2265 (Electronic) Linking ISSN: 03000664 NLM ISO Abbreviation: Clin Endocrinol (Oxf) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2265 |
|---|---|
| DOI: | 10.1111/cen.15012 |
